Petosemtamab Evidence: Trial Results and Peer-Reviewed Publications

Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated:

The clinical evidence base for Petosemtamab comprises 1 peer-reviewed publications across 1 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Squamous Cell Carcinoma of Head and Neck. Most recent publication: LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC., Future Oncol, 2025.

Top peer-reviewed publications

Curated set of pivotal-trial result papers and recent publications in high-tier journals.

  1. LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC.
    Machiels JP, Fayette J, Haddad R, et al. · Future Oncol · 2025
    PubMed: PMID 40511820 · NCT06496178 · Squamous Cell Carcinoma of Head and Neck

Publications by year

2025–2025: 1 publications.

2025
1

Publications by indication

Squamous Cell Carcinoma of Head and Neck (1)

  • LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC.
    Future Oncol · 2025 · PMID 40511820 · NCT06496178

Publications by journal

  • Future Oncol1 paper

All Petosemtamab publications (1)

2025 (1 paper)

  1. LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC.
    Machiels JP, Fayette J, Haddad R, et al. · Future Oncol · 2025 · Derived
    PubMed: PMID 40511820 · NCT06496178 · Squamous Cell Carcinoma of Head and Neck

Sources and methodology

  • Publications: ctgov.study_references (PubMed PMIDs auto-attached by ClinicalTrials.gov to each trial), reference types RESULT, DERIVED, and BACKGROUND.
  • Per-arm outcome values: ctgov.outcome_measurements joined to ctgov.design_outcomes where outcome_type = 'PRIMARY', restricted to phase PHASE3 and PHASE2/PHASE3.
  • Publication metadata (title, journal, year, authors): PubMed E-utilities efetch.fcgi
  • Data freshness: Tue, 02 Jun 2026 17:37:49 GMT.
This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).